• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number PLC231200
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Aneurysm (1708)
Date of Event 09/17/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The gore® excluder® aaa endoprosthesis instructions for use (ifu) states that adverse events that may occur and/or require intervention include, but are not limited to endoleak.
 
Event or Problem Description
The fsa reported: on (b)(6) 2021, the patient was implanted with a gore® excluder® aaa endoprostheses to treat an abdominal aortic aneurysm.The patient tolerated the procedure.During the initial implant procedure, the contralateral leg endoprosthesis was overlapped by 3-4cm.It was reported that images (date and modality is unknown), revealed a type iii endoleak (component disconnection) due to device distal migration.There is no aneurysm sac enlargement.On (b)(6) 2021, a reintervention occurred.The physician implanted a contralateral leg endoprosthesis (231400 limb) across the two disconnected parts.The doctors gained access through the disunion and bridged it with a contralateral leg endoprosthesis (231400 limb).The patient tolerated the procedure.
 
Additional Manufacturer Narrative
Addition h6 impact code.Addition h6 component code.Addition h6: code 213-the review of the manufacturing paperwork verified that this lot met all pre-release specifications.Addition h6: code 4315-cause of endoleak could not be established addition computed tomography images dated (b)(6) 2021, were evaluated by gore imaging services.The imaging evaluation stated there is no overlap between the ipsilateral limb of the main body and the contra-lateral limb used as an ipsi-limb extension.Unable to assess the alleged distal device migration using the available images.There appears to be approximately 12mm from the end of the l contra-limb extension to the l hypogastric artery.The cause of the endoleak could not be established.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL SILICON VALLEY B/P
2890 de la cruz blvd.
santa clara CA 95050
Manufacturer Contact
rachael chascsa
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key12586965
Report Number3013164176-2021-01251
Device Sequence Number11063921
Product Code MIH
UDI-Device Identifier00733132618569
UDI-Public00733132618569
Combination Product (Y/N)N
Initial Reporter StateKS
Initial Reporter CountryUS
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/15/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/27/2024
Device Model NumberPLC231200
Device Catalogue NumberPLC231200
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 09/17/2021
Supplement Date Received by Manufacturer09/17/2021
Initial Report FDA Received Date10/06/2021
Supplement Report FDA Received Date12/15/2021
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured03/29/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age83 YR
Patient SexFemale
-
-